Persantine bioavailability problems
Lehmann, C.R.; Locke, K.; Pierson, W.P.; Shaffer, P.J.; Hall, W.
Clinical Pharmacy 3(1): 14-15
1984
ISSN/ISBN: 0278-2677 PMID: 6697671 Document Number: 231418
Document emailed within 1 workday
Related Documents
1980: Persantine and aspirin in coronary heart disease. The Persantine-Aspirin Reinfarction Study Research Group Circulation 62(3): 449-461Bekemeier, H.; Hirschelmann, R. 1984: Bioavailability of drugs--concepts and problems Die Pharmazie 39(1): 59-62
Cascioli, D.; Petrangeli, B. 1978: Drug absorption and bioavailability problems of tablets and capsules Bollettino Chimico Farmaceutico 117(8): 437-451
Thakkar, A.L.; Hirsch, C.A.; Page, J.G. 1977: Solid dispersion approach for overcoming bioavailability problems due to polymorphism of nabilone, a cannabinoid derivative Journal of Pharmacy and Pharmacology 29(12): 783-784
Firsov, A.A.; Piotrovskii, V.K. 1986: Methods for estimating drug bioavailability parameters. Part 3: Peculiarities of pharmacokinetic analysis in assessment of bioavailability Die Pharmazie 41(7): 457-465
Picano, E.; Sicari, R.; Baroni, M.; Del Negro, B.; Michelassi, C.; Pirelli, S.; Chiarandà, G.; Previtali, M.; Seveso, G.; Gandolfo, N.; Vassalle, C.; Margaria, F.; Magaia, O.; Bianchi, F.; Minardi, G.; Landi, P.; Raciti, M.; Severi, S. 1997: The relative value of exercise-electrocardiography and dipyridamole stress echocardiography for risk stratification early after uncomplicated myocardial infarction. The EPIC (Echo Persantine International Cooperative) Study Group Giornale Italiano di Cardiologia 27(1): 32-39
Baer, J.E.; Hucker, H.B.; Duggan, D.E. 1974: Bioavailability of indomethacin in man Annals of Clinical Research 6(Suppl 11): 44-47
Bates, C.J. 1997: Bioavailability of vitamin C European Journal of Clinical Nutrition 51(Suppl 1): S28-S33
Fraser, E.J.; Leach, R.H.; Poston, J.W. 1972: Bioavailability od digoxin Lancet 2(7776): 541
Walkenstein, S.S.; Dubb, J.W.; Randolph, W.C.; Westlake, W.J.; Stote, R.M.; Intoccia, A.P. 1978: Bioavailability of cimetidine in man Gastroenterology 74(2 Part 2): 360-365
Shrimanker, K.; Akpoviroro, J.; Fotherby, K.; Watson, J. 1980: Bioavailability of Lynestrenol Arzneimittel-Forschung 30(3): 500-502
Padeletti, L.; Brat, A. 1978: Bioavailability of digoxin in capsules International Journal of Clinical Pharmacology and Biopharmacy 16(7): 320-322
Wittmann, D.H.; Schassan, H.H. 1983: Bioavailability of antibiotics in peritonitis Schweizerische Rundschau für Medizin Praxis 72(11): 363-368
Weber, N.E. 1982: Bioavailability of bound residues Toxicological European Research. Recherche Europeenne en Toxicologie 4(5): 271-275
Kaojarern, S.; Sriapa, C.; Sirivarasai, J.; Tongpoo, A.; Thareerach, M. 1999: Comparative bioavailability of paracetamol Journal of the Medical Association of Thailand 82(11): 1149-1153
Wiela-Hojeńska, A.; Orzechowska-Juzwenko, K. 2003: Bioavailability and its significance in pharmacotherapy Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 14(79): 89-93
Rupp, W.; Christ, O.; Fülberth, W. 1972: Studies on the bioavailability of glibenclamide Arzneimittel-Forschung 22(2): 471-473
Bornschein, M.; Grohmann, A.; Hackenberger, F.; Grune, D. 1981: The bioavailability of trapidil from suppositories Die Pharmazie 36(12): 830-832
Fritz, J.C.; Pla, G.W.; Harrison, B.N.; Clark, G.A. 1975: Estimation of the bioavailability of iron Journal - Association of Official Analytical Chemists 58(5): 902-905
Coleman, J.H.; Straughn, A.B. 1975: Assurance of drug quality (bioavailability) Diseases of the Nervous System 36(2): 63-64